Patents by Inventor Prem C. Srivastava

Prem C. Srivastava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4812577
    Abstract: A mercuric maleimide is utilized as a pharmaceutical kit for preparing radiohalogenated maleimides.
    Type: Grant
    Filed: February 12, 1988
    Date of Patent: March 14, 1989
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: Prem C. Srivastava
  • Patent number: 4764598
    Abstract: A class of radiolabeled compounds to be used in tissue imaging that exhibits rapid brain uptake, good brain:blood radioactivity ratios, and long retention times. The imaging agents are more specifically radioiodinated aromatic amines attached to dihydropyridine carriers, that exhibit heart as well as brain specificity. In addition to the radiolabeled compounds, classes of compounds are also described that are used as precursors and intermediates in the preparation of the imaging agents.
    Type: Grant
    Filed: March 13, 1987
    Date of Patent: August 16, 1988
    Assignee: The United States of America as represented by the Department of Energy
    Inventors: Prem C. Srivastava, Furn F. Knapp, Jr.
  • Patent number: 4735792
    Abstract: A radiopharmaceutical for antibody labeling comprising an iodophenyl maleimide that attaches thiol sites of proteins thereby maintaining bioreactivity largely located at the nitrogen sites.
    Type: Grant
    Filed: April 28, 1987
    Date of Patent: April 5, 1988
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventor: Prem C. Srivastava
  • Patent number: 4594414
    Abstract: A class of novel 2-.beta.-D-ribofuranosylselenazole-4-carboxamide nucleoside and nucleotide compounds and methods for their production are provided. Compounds of the class typically have pharmacological properties, especially antitumor and antiviral properties, and are well tolerated, being useful, for example, in treating tumors and viral infections in warm blooded animals.
    Type: Grant
    Filed: June 22, 1984
    Date of Patent: June 10, 1986
    Assignee: Brigham Young University
    Inventors: Roland K. Robins, Prem C. Srivastava
  • Patent number: 4594416
    Abstract: A class of novel 2-.beta.-D-ribofuranosylselenazole-4-carboxamide nucleoside and nucleotide compounds and methods for their production are provided. Compounds of the class typically have pharmacological properties, especially antitumor and antiviral properties, and are well tolerated, being useful, for example, in treating tumors and viral infections in warm blooded animals.
    Type: Grant
    Filed: July 23, 1984
    Date of Patent: June 10, 1986
    Assignee: Brigham Young University
    Inventors: Roland K. Robins, Prem C. Srivastava
  • Patent number: 4531001
    Abstract: A class of novel 2-.beta.-D-ribofuranosylselenazole-4-carboxamide nucleoside and nucleotide compounds and methods for their production are provided. Compounds of the class typically have pharmacological properties, especially antitumor and antiviral properties, and are well tolerated, being useful, for example, in treating tumors and viral infections in warm blooded animals.
    Type: Grant
    Filed: February 15, 1983
    Date of Patent: July 23, 1985
    Assignee: Brigham Young University
    Inventors: Roland K. Robins, Prem C. Srivastava
  • Patent number: 4461891
    Abstract: 2-.beta.-D-Ribofuranosylthiazole-4-carboxamidine (I) and salts are provided as well as a means for their production and use. The compounds typically show unique pharmacological activity, especially antienzyme and cytotoxic activity.
    Type: Grant
    Filed: March 2, 1983
    Date of Patent: July 24, 1984
    Assignee: Brigham Young University
    Inventors: Roland K. Robins, Prem C. Srivastava